SCHEMBL31474607

SCHEMBL31474607

[O-][S@+]1CCc2nc(Cl)nc(NC34CC(CO)(C3)C4)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31491332 0.82 — —
SCHEMBL30639365 0.81 — —
SCHEMBL30639341 0.80 LATS1 (0.32) —
SCHEMBL29576569 0.80 LATS1 (0.32) —
SCHEMBL31571836 0.80 LATS1 (0.32) —
SCHEMBL30639342 0.80 LATS1 (0.32) —
SCHEMBL23068549 0.79 — —
SCHEMBL23068548 0.79 — —
SCHEMBL31491333 0.79 — —
SCHEMBL31630529 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008788-A1 AZA-FUSED RING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE SUZHOU ARK BIOPHARMACEUTICAL CO LTD (CN) 2026-01-08 — — US disclosed
WO-2025067168-A1 AZA FUSED RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 苏州爱科百发生物医药技术有限公司 2025-04-03 — — WO disclosed
CN-119698422-A Aza condensed ring compound, preparation method and medical application thereof 苏州爱科百发生物医药技术有限公司 2025-03-25 — — CN disclosed
Send feedback